Benefit-Risk Assessment of advanced continuous manufacturing technologies
Conference Dates
October 5-9, 2025
Abstract
Please click Additional Files below to see the full abstract
Recommended Citation
Ushma Mehta, "Benefit-Risk Assessment of advanced continuous manufacturing technologies" in "Integrated Continuous Biomanufacturing VII (ICB VII)", Irina Ramos, AstraZeneca; Mark Brower, Merck; Alois Jungbauer, BOKU; K. Brower, Sanofi Eds, ECI Symposium Series, (2025). https://dc.engconfintl.org/biomanufact_vii/36
78.pdf (71 kB)
COinS